newsfilter
← Latest News
PR Newswire·

Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Sept. 5, 2023 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ:BPMC), today announced that, effective September 1, 2023, the Compensation Committee of Blueprint Medicines' Board of Directors